Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
8.49
-0.13 (-1.51%)
At close: Oct 27, 2025, 4:00 PM EDT
8.50
+0.01 (0.11%)
Pre-market: Oct 28, 2025, 8:05 AM EDT
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $729.24 million as of October 28, 2025. Its market cap has increased by 67.64% in one year.
Market Cap
729.24M
Enterprise Value
628.07M
1-Year Change
67.64%
Ranking
Category
Stock Price
$8.49
Market Cap Chart
Since October 28, 2015, Anavex Life Sciences's market cap has increased from $284.60M to $729.24M, an increase of 156.23%. That is a compound annual growth rate of 9.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 740.00M | -18.76% |
| Dec 31, 2024 | 910.90M | 19.20% |
| Dec 29, 2023 | 764.20M | 5.86% |
| Dec 30, 2022 | 721.90M | -45.24% |
| Dec 31, 2021 | 1.32B | 264.55% |
| Dec 31, 2020 | 361.60M | 148.69% |
| Dec 31, 2019 | 145.40M | 100.00% |
| Dec 31, 2018 | 72.70M | -48.95% |
| Dec 29, 2017 | 142.40M | -9.24% |
| Dec 30, 2016 | 156.90M | -18.58% |
| Dec 31, 2015 | 192.70M | -32.29% |
| Oct 28, 2015 | 284.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 733.89B |
| Johnson & Johnson | 456.37B |
| AbbVie | 403.09B |
| UnitedHealth Group | 329.67B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 219.11B |